Starbucks Jumps After New Menu Helps Reverse Stagnant U.S. Sales
(Bloomberg) -- Starbucks Corp. broke out of its home-market slump, posting better-than-expected sales in the U.S. that sparked a share rally in late trading.
- Comparable sales -- the key gauge of retail performance -- rose 4 percent in the Americas, beating analysts' estimate for a gain of 2.8 percent and far-outpacing the previous quarter's sluggish pace. Sales also beat globally.
Key Insights
- Starbucks considers the U.S. and China its most important markets, and it's making progress in both. The chain, which is expanding delivery service in China, saw 1 percent same-store sales growth in the Asia Pacific region last quarter, reversing the previous period's temporary dip.
- The world's biggest coffee chain, which rode demand for its Frappuccinos to ubiquity, is shifting to healthier beverages in addition to expanding its food menu. New drinks and food helped drive the company's U.S. comparable sales beat last quarter, Chief Executive Officer Kevin Johnson said in an interview.
- Starbucks said it's sharpening its focus on shareholder returns by simplifying the business. It has already moved to restructure in the U.S. and Europe, trimming its bloated payroll. The move, coupled with accelerated share buybacks, may appease shareholders that now include billionaire Bill Ackman.
Market Reaction
- Shares rose as much as 10 percent to $64.48 as of 4:28 p.m. after the end of regular trading in New York. The stock was already up 2.1 percent this year through Thursday's close.
- Get more on the results here.
More Details
- Starbucks sees full-year adjusted earnings at $2.61 to $2.66 a share.
©2018 Bloomberg L.P.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.